Low-dose Rituximab Regimens in Chinese Adult Patients With Immune Thrombocytopenia

Clinical trial NCT01719692 · COMPLETED

Trial details

NCT number: NCT01719692
Sponsor: Institute of Hematology & Blood Diseases Hospital, China
Status: COMPLETED
Phase: Not Applicable
Study type: INTERVENTIONAL

Immune Thrombocytopenic Purpura

Start date: 2012-10-01
Primary completion: 2015-10-01
Enrollment: 100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.